| Views | |
|---|---|
| Binimetinib Encorafenib and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study | 45 |
| February 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|
| Binimetinib Encorafenib and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study | 29 | 7 | 3 | 5 | 1 |
| Views | |
|---|---|
| artconlli_a2019_tabernero_josep_binimetinib_encorafenib.pdf | 11 |
| Views | |
|---|---|
| United States | 15 |
| China | 7 |
| Canada | 2 |
| Spain | 1 |
| Views | |
|---|---|
| Menlo Park | 8 |
| Shanghai | 6 |
| Oakland | 5 |
| Ottawa | 2 |
| Barcelona | 1 |
| Guangzhou | 1 |
| Jackson | 1 |
| San Diego | 1 |